Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-007710
Filing Date
2017-05-02
Accepted
2017-05-02 10:01:32
Documents
52
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oxfd20170331_10q.htm 10-Q 914382
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 15677
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 15571
4 EXHIBIT 32 ex32.htm EX-32 6321
  Complete submission text file 0001437749-17-007710.txt   3618159

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS oxfd-20170331.xml EX-101.INS 677745
6 EXHIBIT 101.SCH oxfd-20170331.xsd EX-101.SCH 35308
7 EXHIBIT 101.CAL oxfd-20170331_cal.xml EX-101.CAL 38512
8 EXHIBIT 101.DEF oxfd-20170331_def.xml EX-101.DEF 239427
9 EXHIBIT 101.LAB oxfd-20170331_lab.xml EX-101.LAB 204688
10 EXHIBIT 101.PRE oxfd-20170331_pre.xml EX-101.PRE 254218
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36200 | Film No.: 17803267
SIC: 2835 In Vitro & In Vivo Diagnostic Substances